1. Home
  2. CRUS vs ALKS Comparison

CRUS vs ALKS Comparison

Compare CRUS & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRUS
  • ALKS
  • Stock Information
  • Founded
  • CRUS 1984
  • ALKS 1987
  • Country
  • CRUS United States
  • ALKS Ireland
  • Employees
  • CRUS N/A
  • ALKS N/A
  • Industry
  • CRUS Semiconductors
  • ALKS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRUS Technology
  • ALKS Health Care
  • Exchange
  • CRUS Nasdaq
  • ALKS Nasdaq
  • Market Cap
  • CRUS 5.2B
  • ALKS 4.5B
  • IPO Year
  • CRUS 1989
  • ALKS 1991
  • Fundamental
  • Price
  • CRUS $106.23
  • ALKS $31.42
  • Analyst Decision
  • CRUS Strong Buy
  • ALKS Buy
  • Analyst Count
  • CRUS 6
  • ALKS 12
  • Target Price
  • CRUS $124.50
  • ALKS $38.33
  • AVG Volume (30 Days)
  • CRUS 630.0K
  • ALKS 1.7M
  • Earning Date
  • CRUS 05-06-2025
  • ALKS 05-01-2025
  • Dividend Yield
  • CRUS N/A
  • ALKS N/A
  • EPS Growth
  • CRUS 22.45
  • ALKS N/A
  • EPS
  • CRUS 6.00
  • ALKS 2.09
  • Revenue
  • CRUS $1,896,077,000.00
  • ALKS $1,513,770,000.00
  • Revenue This Year
  • CRUS N/A
  • ALKS N/A
  • Revenue Next Year
  • CRUS $8.09
  • ALKS $4.09
  • P/E Ratio
  • CRUS $17.76
  • ALKS $15.04
  • Revenue Growth
  • CRUS 5.99
  • ALKS N/A
  • 52 Week Low
  • CRUS $75.83
  • ALKS $22.90
  • 52 Week High
  • CRUS $147.46
  • ALKS $36.45
  • Technical
  • Relative Strength Index (RSI)
  • CRUS 67.81
  • ALKS 58.91
  • Support Level
  • CRUS $91.32
  • ALKS $30.38
  • Resistance Level
  • CRUS $108.66
  • ALKS $31.56
  • Average True Range (ATR)
  • CRUS 2.68
  • ALKS 1.01
  • MACD
  • CRUS 1.41
  • ALKS 0.30
  • Stochastic Oscillator
  • CRUS 85.99
  • ALKS 86.52

About CRUS Cirrus Logic Inc.

Cirrus Logic Inc is a provider of integrated circuits for audio and voice signal processing applications. The firm's products are organized into two streams: portable audio products, and HPMS Products. These products include aAmplifiers, codecs, smart codecs, analog-to-digital converters, digital-to-analog converters and standalone digital signal processors, Camera controllers, haptics and sensing solutions, and battery and power ICs. Roughly half of the firm's revenue is generated in China, with the rest coming from the United States, Europe, South Korea, and countries across the world.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: